Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George F Murphy

Showing results (151-160 of 193) with videos related to

Pageof 20
Sort By:
The Journal of Experimental Medicine|September 10, 2009
NOD2 regulates hematopoietic cell function during graft-versus-host diseaseOlaf Penack, Odette M Smith, Amy Cunningham-Bussel, et al.
Cell Reports|August 10, 2022
Limbal BCAM expression identifies a proliferative progenitor population capable of holoclone formation and corneal differentiationYuzuru Sasamoto, Catherine A A Lee, Brian J Wilson, et al.
Nature Medicine|November 12, 2002
T cells require TRAIL for optimal graft-versus-tumor activityCornelius Schmaltz, Onder Alpdogan, Barry J Kappel, et al.
Blood|January 8, 2008
Organ-derived dendritic cells have differential effects on alloreactive T cellsTheo D Kim, Theis H Terwey, Johannes L Zakrzewski, et al.
Cytotherapy|March 18, 2019
In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trialsNils Tappenbeck, Hannes M Schröder, Elke Niebergall-Roth, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host diseaseTeresa Ramirez-Montagut, Andrew Chow, Adam A Kochman, et al.
Blood|July 23, 2005
CCR2 is required for CD8-induced graft-versus-host diseaseTheis H Terwey, Theo D Kim, Adam A Kochman, et al.
The Journal of Biological Chemistry|May 24, 2018
ATP-binding cassette member B5 (ABCB5) promotes tumor cell invasiveness in human colorectal cancerQin Guo, Tanja Grimmig, Gabriel Gonzalez, et al.
The Journal of Investigative Dermatology|February 2, 2016
ABCB5-Targeted Chemoresistance Reversal Inhibits Merkel Cell Carcinoma GrowthSonja Kleffel, Nayoung Lee, Cecilia Lezcano, et al.
The Journal of Investigative Dermatology|March 11, 2015
Melanoma Cell Galectin-1 Ligands Functionally Correlate with Malignant PotentialErika M Yazawa, Jenna E Geddes-Sweeney, Filiberto Cedeno-Laurent, et al.
Pageof 20

Showing results (151-160 of 193) with videos related to

Sort By:
Pageof 20
The Journal of Experimental Medicine|September 10, 2009
NOD2 regulates hematopoietic cell function during graft-versus-host diseaseOlaf Penack, Odette M Smith, Amy Cunningham-Bussel, et al.
Cell Reports|August 10, 2022
Limbal BCAM expression identifies a proliferative progenitor population capable of holoclone formation and corneal differentiationYuzuru Sasamoto, Catherine A A Lee, Brian J Wilson, et al.
Nature Medicine|November 12, 2002
T cells require TRAIL for optimal graft-versus-tumor activityCornelius Schmaltz, Onder Alpdogan, Barry J Kappel, et al.
Blood|January 8, 2008
Organ-derived dendritic cells have differential effects on alloreactive T cellsTheo D Kim, Theis H Terwey, Johannes L Zakrzewski, et al.
Cytotherapy|March 18, 2019
In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trialsNils Tappenbeck, Hannes M Schröder, Elke Niebergall-Roth, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host diseaseTeresa Ramirez-Montagut, Andrew Chow, Adam A Kochman, et al.
Blood|July 23, 2005
CCR2 is required for CD8-induced graft-versus-host diseaseTheis H Terwey, Theo D Kim, Adam A Kochman, et al.
The Journal of Biological Chemistry|May 24, 2018
ATP-binding cassette member B5 (ABCB5) promotes tumor cell invasiveness in human colorectal cancerQin Guo, Tanja Grimmig, Gabriel Gonzalez, et al.
The Journal of Investigative Dermatology|February 2, 2016
ABCB5-Targeted Chemoresistance Reversal Inhibits Merkel Cell Carcinoma GrowthSonja Kleffel, Nayoung Lee, Cecilia Lezcano, et al.
The Journal of Investigative Dermatology|March 11, 2015
Melanoma Cell Galectin-1 Ligands Functionally Correlate with Malignant PotentialErika M Yazawa, Jenna E Geddes-Sweeney, Filiberto Cedeno-Laurent, et al.
Pageof 20